Rapid normalization of the dexamethasone suppression test with mianserin

Area of Science:

• Psychiatry
• Neuroendocrinology
• Clinical Pharmacology

Background:

• The dexamethasone suppression test (DST) is a diagnostic tool used in psychiatry.
• Abnormal DST results are frequently observed in patients with depression and schizophrenia.
• The influence of specific psychotropic medications on DST outcomes requires further investigation.

Purpose of the Study:

• To evaluate the impact of certain psychiatric medications on the results of the dexamethasone suppression test (DST).
• To determine if treatments like mianserin, chlorpromazine, ECT, or haloperidol affect DST suppression in patients with depression and schizophrenia.

Main Methods:

• Dexamethasone suppression tests (DSTs) were administered to 8 patients (6 with depression, 2 with schizophrenia) before and after initiating treatment.
• Patients received treatments including mianserin, chlorpromazine, electroconvulsive therapy (ECT), or haloperidol.
• Repeat DSTs were performed 48 to 72 hours after treatment initiation.

Main Results:

• All 8 patients were non-suppressors on the initial DST.
• Following treatment, 5 patients on mianserin and 1 on chlorpromazine showed normal DST suppression, irrespective of clinical improvement.
• Two patients treated with ECT or haloperidol continued to exhibit non-suppression on repeat DSTs.

Conclusions:

• Mianserin and chlorpromazine may be associated with false-negative DST results in psychiatric patients.
• These findings suggest that certain medications can interfere with the DST, potentially leading to inaccurate diagnostic interpretations.
• Further research into the mechanisms underlying medication-induced DST alterations is warranted.